Cover Story
DEPARTMENTS
Focus on Breast Cancer
Focus on Lung Cancer
News & Analysis
Focus on Prostate Cancer
Nivolumab Combo Yields Durable Survival Benefit in Metastatic NSCLC
June 5th 2023Nivolumab plus ipilimumab and chemotherapy also appears to produce a higher overall response rate compared with chemotherapy alone among those with squamous non–small cell lung cancer in the phase 3 CheckMate 9LA trial.
Oncology On-The-Go Podcast: De-escalating Breast Cancer Treatment
May 8th 2023Rakhshanda Rahman, MD, FRCS, FACS, emphasizes the importance of educating patients and physicians on the potential risks and benefits of new approaches and technologies involved in the de-escalation of breast cancer treatment.
Neoadjuvant Nivolumab/Chemo Improves Outcomes Vs Chemo in Resectable NSCLC
June 4th 2023Patients who receive nivolumab plus chemotherapy for non–small cell lung cancer may experience sustained improvement in time to death or distant metastasis, according to an expert from McGill University Health Center.
2 Clarke Drive
Cranbury, NJ 08512